Paul Bien
Corporate Officer/Principal en Amplyx Pharmaceuticals, Inc. .
Origen de la red de primer grado Paul Bien.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Paul Bien a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member | |
| TRILLIUM THERAPEUTICS | Biotechnology | President | |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Founder | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
First Aid Beverages, Inc.
 First Aid Beverages, Inc. Pharmaceuticals: MajorHealth Technology First Aid Beverages, Inc. develops and commercializes comprehensive portfolio of over-the-counter pharmaceutical products. It develops liquid formulated single-dose products for treating pain and upset stomach symptoms. The company was founded by Mary Page Platerink and Jay Pasricha in 2010 and is headquartered in Burlingame, CA. | Pharmaceuticals: Major | Director/Board Member | |
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Corporate Officer/Principal | |
RiverVest Venture Management LLC
 RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| University Of Dundee | College/University | Doctorate Degree | |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OWENS CORNING | Containers/Packaging | Corporate Officer/Principal | |
| Civitas | Corporate Officer/Principal | ||
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
| MERUS N.V. | Biotechnology | Chairman | |
| Coopers & Lybrand Consulting, Inc. | Corporate Officer/Principal | ||
Sofinnova Management VIII LLC
 Sofinnova Management VIII LLC Miscellaneous Commercial ServicesCommercial Services Sofinnova Management VIII LLC is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JPMorgan Private Capital Asia Corp.
 JPMorgan Private Capital Asia Corp. Investment ManagersFinance JPMorgan Private Capital Asia Corp (JPMorgan Asia) is a private equity arm of JPMorgan Chase Co founded in 2006. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| Hoosier Oncology Group, Inc. | Founder | ||
| Rady School of Management at UC San Diego | College/University | Masters Business Admin | |
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Pembroke College Oxford | College/University | Graduate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
January Therapeutics, Inc.
 January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
Sparrow Pharmaceuticals, Inc.
 Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Pharmaceuticals: Major | Director/Board Member | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Chief Executive Officer | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 46 |
| Reino Unido | 4 |
| Canadá | 2 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 4 |
| Process Industries | 2 |
Operativa
| Director/Board Member | 55 |
| Corporate Officer/Principal | 16 |
| Independent Dir/Board Member | 13 |
| Chief Executive Officer | 9 |
| Founder | 8 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Elaine Heron | 23 |
| Paul Grint | 22 |
| Anand Mehra | 18 |
| Niall O'Donnell | 17 |
| Chris LeMasters | 15 |
| Deborah Baron | 9 |
- Bolsa de valores
- Insiders
- Paul Bien
- Conexiones Empresas
